Decoy Therapeutics, Inc. (DCOY)
2.92
-0.05
(-1.68%)
USD |
NASDAQ |
Aug 28, 16:00
2.86
-0.06
(-2.05%)
After-Hours: 19:37
Decoy Therapeutics Cash from Operations (Quarterly) : -2.652M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.652M |
| March 31, 2026 | -2.889M |
| December 31, 2025 | -1.136M |
| September 30, 2025 | -1.647M |
| June 30, 2025 | -0.8623M |
| March 31, 2025 | -1.182M |
| December 31, 2024 | -0.7425M |
| September 30, 2024 | -1.357M |
| June 30, 2024 | -1.072M |
| March 31, 2024 | -1.354M |
| December 31, 2023 | -1.511M |
| September 30, 2023 | -3.749M |
| June 30, 2023 | -4.416M |
| March 31, 2023 | -3.169M |
| December 31, 2022 | -4.714M |
| September 30, 2022 | -5.741M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -2.721M |
| September 30, 2021 | -1.582M |
| June 30, 2021 | -3.175M |
| March 31, 2021 | -2.723M |
| December 31, 2020 | -1.374M |
| September 30, 2020 | -2.753M |
| Date | Value |
|---|---|
| June 30, 2020 | -2.477M |
| March 31, 2020 | -3.708M |
| December 31, 2019 | -2.637M |
| September 30, 2019 | -5.542M |
| June 30, 2019 | -1.533M |
| March 31, 2019 | -1.869M |
| December 31, 2018 | 0.3875M |
| September 30, 2018 | 21.46M |
| June 30, 2018 | -8.255M |
| March 31, 2018 | -9.412M |
| December 31, 2017 | -5.755M |
| September 30, 2017 | -8.051M |
| June 30, 2017 | -5.69M |
| March 31, 2017 | -8.226M |
| December 31, 2016 | -6.298M |
| September 30, 2016 | -7.252M |
| June 30, 2016 | -9.328M |
| March 31, 2016 | -9.174M |
| December 31, 2015 | -5.437M |
| September 30, 2015 | -6.704M |
| June 30, 2015 | -4.465M |
| March 31, 2015 | -4.141M |
| December 31, 2014 | -3.89M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Palatin Technologies, Inc. | -4.417M |
| Unicycive Therapeutics, Inc. | -7.604M |
| Nuvectis Pharma, Inc. | -4.531M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0424M |
| Cash from Financing (Quarterly) | 3.163M |
| Free Cash Flow | -8.367M |
| Free Cash Flow Per Share (Quarterly) | -5.065 |
| Free Cash Flow to Equity (Quarterly) | -2.694M |
| Free Cash Flow to Firm (Quarterly) | -2.694M |
| Free Cash Flow Yield | -700.5% |